Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Unity Biotechnology, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
10.86%
EBIT to Interest (avg)
-44.90
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
13.03
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
25.26%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-11.72
EV to EBIT
0.04
EV to EBITDA
0.04
EV to Capital Employed
0.10
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
234.34%
ROE (Latest)
Negative BV
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bearish
Bollinger Bands
Sideways
Sideways
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -22.03 MM
NET PROFIT(HY)
Higher at USD -13.73 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -2,753.17 %
-3What is not working for the Company
ROCE(HY)
Lowest at -231.27%
CASH AND EQV(HY)
Lowest at USD 40.16 MM
Here's what is working for Unity Biotechnology, Inc.
Operating Cash Flow
Highest at USD -22.03 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD -13.73 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Debt-Equity Ratio
Lowest at -2,753.17 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Unity Biotechnology, Inc.
Cash and Eqv
Lowest at USD 40.16 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






